Page last updated: 2024-11-02

papaverine and Delayed Effects, Prenatal Exposure

papaverine has been researched along with Delayed Effects, Prenatal Exposure in 2 studies

Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Luhach, K1
Kulkarni, GT1
Singh, VP1
Sharma, B2
Sharma, N1
Dhiman, N1
Golani, LK1

Other Studies

2 other studies available for papaverine and Delayed Effects, Prenatal Exposure

ArticleYear
Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD.
    European journal of pharmacology, 2021, Jan-05, Volume: 890

    Topics: Animals; Anticonvulsants; Autism Spectrum Disorder; Dose-Response Relationship, Drug; Doublecortin P

2021
Papaverine ameliorates prenatal alcohol-induced experimental attention deficit hyperactivity disorder by regulating neuronal function, inflammation, and oxidative stress.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2021, Volume: 81, Issue:1

    Topics: Animals; Anxiety; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Cell Survival; Cy

2021